GoodRx (GDRX) Q2 2026 Earnings Call Transcript
Pharma Direct revenue surged 76% as GLP-1 demand accelerated.
Pharma Direct revenue surged 76% as GLP-1 demand accelerated.
BELLINGS Intelligence Score: 12
Why it matters
GoodRx's Q2 earnings reflect strong growth in Pharma Direct revenue driven by GLP-1 demand, which is notable company-specific performance but does not materially affect credit markets or broader credit conditions.
Sources
The Motley Fool
GoodRx (GDRX) Q2 2026 Earnings Call Transcript
Pharma Direct revenue surged 76% as GLP-1 demand accelerated.
The Motley Fool
KLIC Q3 2026 Earnings Call Transcript
Wire bonding capacity surged fourfold as data center demand accelerated.
The Motley Fool
Ouster (OUST) Q2 2026 Earnings Call Transcript
Revenue surged 56% year over year as lidar shipments accelerated.